Company Search:
Advanced Search
Sponsored Links
Pluristem Therapeutics Incorporation. Company Snapshot
Pluristem Therapeutics Incorporation. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pluristem Therapeutics Incorporation. with three other pharmaceutical manufacturers in North America: Kyto Technology and Life Science Inc (2020 sales of $14,150.00 ), Alterity Therapeutics Ltd ($11,473.01 of which 100% was Reaserch and development in the field of), and Burcon NutraScience Corp which is based in CANADA (31,134.00 Canadian Dollars [US$23,409.03 ] of which 100% was Protein Ingredients).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pluristem Therapeutics Incorporation.
  Stock Performance Chart for Pluristem Therapeutics Incorporation.
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 10.09
(Figures in U.S. Dollars)
1 Week -1.3%   13 Weeks 0.8%  
4 Weeks 31.7%   52 Weeks 143.7%  
Pluristem Therapeutics Incorporation. Key Data:
  Ticker: PSTI Country: Israel
  Exchanges: NAS OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 23,000
(Year Ending Jan 2021).
Employees: 158
  Currency: U.S. Dollars Market Cap: 257,221,474
  Fiscal Yr Ends: June Shares Outstanding: 25,492,713
  Share Type: Common Closely Held Shares: 4,964,273
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.